Menu
Recruiting NCT07016360

Comparison of Efficacy of Topical Adaplene Gel Versus Crythotherapy in Recurrent Plantar Warts

Phase IV Interventional Viral Warts

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Topical Adapalene Gel 0.1%, Topical Liquid Nitrogen application.
Who it may be relevant to
Registry conditions: Viral Warts. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Efficacy of Topical Adapalene Gel Versus Cryotherapy in Recurrent Plantar Warts

Overview

This is a comparative study between two treatment options for skin viral infection.

Detailed description

This is a comparative study between two treatment for viral infection in epidermal layer of skin that proliferates slowly forming thick, growths. This study will compare and evaluate the differences in efficacy between topical liquid nitrogen and topical retinoids.

Interventions

  • Drug Topical Adapalene Gel 0.1%
    Topical adapalene is a retinoid that helps in epidermal changes. Cryotherapy is a liquid nitrogen applied to affected parts for 6 months
  • Procedure Topical Liquid Nitrogen application
    Liquid Nitrogen will be applied to affected parts.

Primary outcome measures

  • Efficacy of Treatment [Time frame: 06 months]

Eligibility criteria

Inclusion criteria

\-

Patients age limit 18-60 Years Patients with either gender (Male/Female) Patients with recurrent plantar warts

Exclusion criteria

  • Pregnancy/lactation. Pt on topical or systemic therapy in last 6 months. On immunosuppressants. > 5 lesions. Pts with local secondary infections.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Khyber Teaching Hospital — Peshawar

Identifiers

NCT: NCT07016360 · 192/DME/KMC

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗